Reports for NATCO PHARMA (CANADA) INC

Company Name

NATCO PHARMA (CANADA) INC

Totals

Shortage reports

56
Actual shortage: 30 (54%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 26 (46%)

Discontinuation Reports

0
To be discontinued: 0
Discontinued: 0
Reversed: 0

Late reports

1 (2%)

Overdue reports

1 (3%)
Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
NAT-ONDANSETRON 4MG TABLET Resolved 2024-06-13 2025-07-21 230407
NAT-PREGABALIN 225MG CAPSULE Actual shortage 2023-05-17 2024-11-01 192650
NAT-QUETIAPINE 25MG TABLET Resolved 2018-10-31 2022-07-01 65944
NAT-QUETIAPINE 100MG TABLET Resolved 2019-04-17 2022-07-01 81900
NAT-QUETIAPINE 150MG TABLET Resolved 2019-04-23 2021-10-31 82236
NAT-QUETIAPINE 150MG TABLET Actual shortage 2024-04-29 2025-07-03 226594
NAT-QUETIAPINE 200MG TABLET Resolved 2019-04-17 2022-07-01 81903
NAT-QUETIAPINE 300MG TABLET Resolved 2019-04-17 2022-07-01 81906
NAT-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-11-23 2019-02-07 67512
NAT-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Actual shortage 2025-04-04 2025-07-03 254185
NAT-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-11-23 2019-02-07 67515
NAT-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Actual shortage 2025-04-04 2025-07-03 254190
NAT-ZOLMITRIPTAN 2.5MG TABLET Resolved 2024-07-29 2025-06-25 233895
NAT-ZOLMITRIPTAN 2.5MG TABLET Actual shortage 2025-10-28 2025-10-29 270425
NATCO-CITALOPRAM 10MG TABLET Resolved 2024-11-11 2024-11-12 242454
NATCO-CITALOPRAM 10MG TABLET Resolved 2024-11-11 2024-11-12 242457

Showing 41 to 56 of 56

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 1 to 0 of 0